Tag: COVAXIN efficacy

Early Covaxin Study Shows Protections Against Beta & Delta Variants Of Covid-19

Bharat Biotech’s Karnataka facility to manufacture 5 crore Covaxin doses by August-end

COVID Vaccine: DCGI Approves Phase 2/3 Clinical Trial Of Covaxin In Age Group Of 2 To 18 Yrs

Covaxin’s Phase 3 Trial Results Out! Covid-19 Vaccine Efficacy Up At 81%, Says Bharat Biotech

COVAXIN shows interim efficacy of 81% in phase 3 clinical trials